The Other Side

https://www.sciencedaily.com/releases/2026/01/260128230514.htm

Drinking heavily over many years is linked to a higher risk of colorectal cancer, especially rectal cancer, according to new research tracking U.S. adults for two decades. People who drank heavily throughout adulthood faced sharply higher risks than light drinkers. Former drinkers did not show increased cancer risk and had fewer precancerous tumors. The results suggest that quitting alcohol may help lower long-term cancer risk.

https://www.sciencedaily.com/releases/2026/01/260128230514.htm

https://www.sciencedaily.com/releases/2026/01/260128075359.htm

Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain. Researchers found that people regain weight faster after quitting these drugs than after diet and exercise alone. Improvements in heart health and diabetes risk also tend to reverse within a few years. The results suggest long-term success may require more than medication alone.

https://www.sciencedaily.com/releases/2026/01/260128075359.htm

https://www.sciencedaily.com/releases/2026/01/260128075355.htm

JWST has revealed a strange early universe filled with ultra-bright “blue monster” galaxies, mysterious “little red dots,” and black holes that seem far too massive for their age. A new study proposes that dark stars—hypothetical stars powered by dark matter—could tie all these surprises together. These exotic objects may have grown huge very quickly, lighting up the early cosmos and planting the seeds of supermassive black holes.

https://www.sciencedaily.com/releases/2026/01/260128075355.htm

https://www.sciencedaily.com/releases/2026/01/260127112134.htm

Researchers have developed smart nanoparticles that can seek out and destroy disease-causing proteins the body can’t normally eliminate. Unlike traditional drugs, these particles can reach hard-to-access tissues, including the brain, and precisely target problem proteins without widespread side effects. Early results show promise against major cancer drivers, and the platform is designed to be easily adapted to many diseases. The work could reshape the future of precision medicine.

https://www.sciencedaily.com/releases/2026/01/260127112134.htm

https://www.sciencedaily.com/releases/2026/01/260128075319.htm

A massive international study of more than 3,100 long COVID patients uncovered a striking divide in how brain-related symptoms are reported around the world. In the U.S., the vast majority of non-hospitalized patients described brain fog, depression, and anxiety, while far fewer patients in countries like India and Nigeria reported the same issues. The difference doesn’t appear to be about the virus itself, but about culture, stigma, and access to mental health care.

https://www.sciencedaily.com/releases/2026/01/260128075319.htm